Arrowhead Pharmaceuticals (ARWR) P/E (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) P/E from Sep 30, 2010 to Jul 21, 2026. The TTM Arrowhead Pharmaceuticals (ARWR) P/E is -34.44. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Arrowhead Pharmaceuticals (ARWR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -34.44 | -175.95% |
| 2025 | 45.35 | -1338.40% |
| 2024 | -3.66 | -77.06% |
| 2023 | -15.96 | -34.35% |
| 2022 | -24.31 | -35.74% |
| 2021 | -37.84 | -50.59% |
| 2020 | -76.57 | -167.88% |
| 2019 | 112.80 | -408.02% |
| 2018 | -36.62 | +358.32% |
| 2017 | -7.99 | +575.41% |
| 2016 | -1.18 | -71.35% |
| 2015 | -4.13 | -26.60% |
| 2014 | -5.63 | -33.37% |
| 2013 | -8.45 | +644.38% |
| 2012 | -1.13 | -87.76% |
| 2011 | -9.27 | +21.25% |
| 2010 | -7.64 | N/A |
Comparison Arrowhead Pharmaceuticals (ARWR) P/E with competitors
Arrowhead Pharmaceuticals (ARWR) P/E is -34.44.